Autopsy report · NCT00003152
Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
Cause of deathSlow enrollment
“low accrual”
Life of this trial
- Registered 2 years 8 months after it had already started.
- 469 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Sponsor type
- University, hospital or other
- Conditions
- Lymphoma
- Interventions
- filgrastim; recombinant interferon alfa; cyclophosphamide; prednisone; vincristine sulfate; autologous bone marrow transplantation
- Participants
- 469 (planned, not actual)
- Sites
- 2
- Countries
- Netherlands, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.